Literature DB >> 11222822

Pregnancy in systemic lupus erythematosus.

C C Mok1, R W Wong.   

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease that predominantly affects women of reproductive age. Pregnancy and its outcome is a major concern to most SLE patients. Queries regarding the risk of disease flares during pregnancy, chance of fetal loss, and the safety of various drugs are often raised. With the improvement in the understanding of the pathogenesis of SLE and the judicious use of immunosuppressive drugs, better disease control can now be achieved and SLE patients should not be deprived of the opportunity for bearing children. Prepregnancy counselling and close collaboration with other specialists such as the obstetricians and the perinatologists is essential in optimising the maternal and fetal outcome in lupus pregnancies. In this review, important issues regarding the fertility rate, optimal timing of conception, risk of disease flares during lupus pregnancy, pregnancy course, fetal outcome, safety of various drugs used for disease control during pregnancy and lactation, and contraceptive advice are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11222822      PMCID: PMC1741938          DOI: 10.1136/pmj.77.905.157

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  81 in total

1.  Assessing disease activity in SLE patients during pregnancy.

Authors:  J P Buyon; K C Kalunian; R Ramsey-Goldman; M A Petri; M D Lockshin; G Ruiz-Irastorza; M Khamashta
Journal:  Lupus       Date:  1999       Impact factor: 2.911

Review 2.  Pregnancy in SLE.

Authors:  M Petri
Journal:  Baillieres Clin Rheumatol       Date:  1998-08

Review 3.  Antiphospholipid syndrome in pregnancy. Obstetric concerns and treatment.

Authors:  S Welsch; D W Branch
Journal:  Rheum Dis Clin North Am       Date:  1997-02       Impact factor: 2.670

Review 4.  Pregnancy in lupus.

Authors:  C Meng; M Lockshin
Journal:  Curr Opin Rheumatol       Date:  1999-09       Impact factor: 5.006

5.  Factors associated with fetal losses in severe systemic lupus erythematosus.

Authors:  J O Martínez-Rueda; C A Arce-Salinas; A Kraus; J Alcocer-Varela; D Alarcón-Segovia
Journal:  Lupus       Date:  1996-04       Impact factor: 2.911

6.  Pregnancy in women with renal disease and moderate renal insufficiency.

Authors:  S H Hou; S D Grossman; N E Madias
Journal:  Am J Med       Date:  1985-02       Impact factor: 4.965

7.  Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy.

Authors:  D T Boumpas; H A Austin; E M Vaughan; C H Yarboro; J H Klippel; J E Balow
Journal:  Ann Intern Med       Date:  1993-09-01       Impact factor: 25.391

8.  Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus.

Authors:  L Jara-Quezada; A Graef; C Lavalle
Journal:  J Rheumatol       Date:  1991-03       Impact factor: 4.666

9.  Contraceptive practice in women with systemic lupus erythematosus.

Authors:  H A Julkunen; R Kaaja; C Friman
Journal:  Br J Rheumatol       Date:  1993-03

10.  Pregnancy and systemic lupus erythematosus.

Authors:  M T Houser; A J Fish; G E Tagatz; P P Williams; A F Michael
Journal:  Am J Obstet Gynecol       Date:  1980-10-15       Impact factor: 8.661

View more
  11 in total

Review 1.  Current concepts for the management of systemic lupus erythematosus in adults: a therapeutic challenge.

Authors:  Y Ioannou; D A Isenberg
Journal:  Postgrad Med J       Date:  2002-10       Impact factor: 2.401

2.  Nonmalignant diseases and treatments associated with primary ovarian failure: an expanded role for fertility preservation.

Authors:  Jennifer Hirshfeld-Cytron; Clarisa Gracia; Teresa K Woodruff
Journal:  J Womens Health (Larchmt)       Date:  2011-08-09       Impact factor: 2.681

Review 3.  Pathogenesis of systemic lupus erythematosus.

Authors:  C C Mok; C S Lau
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

4.  Contraception for adolescents with lupus.

Authors:  Melissa S Tesher; Amy Whitaker; Melissa Gilliam; Linda Wagner-Weiner; Karen B Onel
Journal:  Pediatr Rheumatol Online J       Date:  2010-03-31       Impact factor: 3.054

Review 5.  Using corticosteroids during pregnancy. Are topical, inhaled, or systemic agents associated with risk?

Authors:  D Oren; I Nulman; M Makhija; S Ito; Gideon Koren
Journal:  Can Fam Physician       Date:  2004-08       Impact factor: 3.275

6.  Early resolution of subretinal fluid without high-dose corticosteroids in a pregnant patient with Vogt-Koyanagi-Harada disease: a case report.

Authors:  Keijiro Sugita; Kyoichi Mizumoto; Nahoko Kato; Masahiro Zako
Journal:  J Ophthalmic Inflamm Infect       Date:  2015-06-27

7.  Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin.

Authors:  Ilaria Pagnini; Gabriele Simonini; Loredana Cavalli; Giancarlo la Marca; Annamaria Iuliano; Maria Luisa Brandi; Francesca Bellisai; Bruno Frediani; Mauro Galeazzi; Luca Cantarini; Rolando Cimaz
Journal:  Pediatr Rheumatol Online J       Date:  2014-10-23       Impact factor: 3.054

8.  Prepregnancy Endocrine, Autoimmune Disorders and the Risks of Gestational Hypertension-Preeclampsia in Primiparas: A Nationwide Population-Based Study in Taiwan.

Authors:  Mei-Lien Pan; Li-Ru Chen; Hsiao-Mei Tsao; Kuo-Hu Chen
Journal:  Int J Environ Res Public Health       Date:  2020-05-22       Impact factor: 3.390

9.  Prognosis of neonates in pregnant women with systemic lupus erythematosus.

Authors:  So-Young Kim; Jung-Hyun Lee
Journal:  Yonsei Med J       Date:  2008-08-30       Impact factor: 2.759

Review 10.  The Complement System in the Pathophysiology of Pregnancy and in Systemic Autoimmune Rheumatic Diseases During Pregnancy.

Authors:  Cecilia Beatrice Chighizola; Paola Adele Lonati; Laura Trespidi; Pier Luigi Meroni; Francesco Tedesco
Journal:  Front Immunol       Date:  2020-08-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.